TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35500975

Group type: EXPERIMENTAL
Intervention: Eutonia
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Holistic Gymnastics
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pilates
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 80
Study: 33176043

Group type: EXPERIMENTAL
Intervention: Gabapentin (100 mg daily for 4 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Doxepin (10 mg daily for 4 weeks)
Number of subjects: 16
Study: 34228123

Group type: EXPERIMENTAL
Intervention: StepCBT-I (web-based CBT-I for less severe insomnia, face-to-face CBT-I for more severe insomnia)
Number of subjects: 177

Group type: COMPARATOR
Intervention: StanCBT-I (6 face-to-face CBT-I sessions)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: StepCBT-I
Number of subjects: 177
Study: 33065822

Group type: EXPERIMENTAL
Intervention: PaRK intervention
Number of subjects: 355

Group type: COMPARATOR
Intervention: Control group (standard web-based educational factsheets)
Number of subjects: 355
Study: 36233500

Group type: COMPARATOR
Intervention: Prophylactic tinzaparin (4500 IU)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Intermediate tinzaparin (100 IU/kg)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Therapeutic tinzaparin (175 IU/kg)
Number of subjects: 300

Group type: COMPARATOR
Intervention: All groups (Prophylactic, Intermediate, Therapeutic)
Number of subjects: 300

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 300
Study: 32723675

Group type: EXPERIMENTAL
Intervention: Neratinib 240 mg/day
Number of subjects: 16
Study: 36064130

Group type: EXPERIMENTAL
Intervention: Autologous platelet-rich gel combined with conventional treatment and TCM
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional therapy and TCM
Number of subjects: 60
Study: 34155984

Group type: EXPERIMENTAL
Intervention: Youper app (AI therapy)
Number of subjects: 4517
Study: 34210720

Group type: EXPERIMENTAL
Intervention: Proactive therapeutic drug monitoring (TDM) arm with infliximab dosing optimised to target higher trough levels (TLI ≥ 25 μg/mL at week 2, ≥ 20 μg/mL at week 6, and ≥ 10 μg/mL during maintenance therapy)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Standard dosing arm with conventional infliximab dosing (5 mg/kg at weeks 0, 2, and 6, and 5 mg/kg 8 weekly thereafter)
Number of subjects: 138
Study: 33085686

Group type: EXPERIMENTAL
Intervention: Message about harmful chemicals
Number of subjects: 2801

Group type: EXPERIMENTAL
Intervention: Message about uncertainty about ingredients
Number of subjects: 2801

Group type: EXPERIMENTAL
Intervention: Message about distrust of big tobacco
Number of subjects: 2801

Group type: EXPERIMENTAL
Intervention: Message about cost of vaping
Number of subjects: 2801

Group type: COMPARATOR
Intervention: Control message (bottled water ad)
Number of subjects: 2801
Study: 33357965

Group type: EXPERIMENTAL
Intervention: Mediterranean dietary intervention with moderate protein restriction
Number of subjects: 502

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 502
Study: 32004214

Group type: EXPERIMENTAL
Intervention: Raltitrexed (Ra) with oxaliplatin (L‐OHP)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Raltitrexed (Ra) with cisplatin (DDP)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Raltitrexed (Ra) with mitomycin C (MMC)
Number of subjects: 38

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 38
Study: 35835256

Group type: EXPERIMENTAL
Intervention: Text messages promoting healthy lifestyle and activity monitor
Number of subjects: 31

Group type: COMPARATOR
Intervention: No text message (comparison days)
Number of subjects: 31
Study: 34186547

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) combined with petrolatum gauze
Number of subjects: 36

Group type: COMPARATOR
Intervention: Petrolatum gauze alone (Control)
Number of subjects: 36
Study: 32017250

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (MBSR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Health education attention control
Number of subjects: 0
Study: 35745125

Group type: EXPERIMENTAL
Intervention: Shelf tag intervention indicating the Health Star Rating (HSR) of all packaged products that scored 4.5 or 5 stars, along with posters for fresh fruits and vegetables.
Number of subjects: 304

Group type: COMPARATOR
Intervention: Control stores without the shelf tag intervention.
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Shelf tag intervention.
Number of subjects: 304
Study: 36052470

Group type: EXPERIMENTAL
Intervention: Online learning using Moodle 2.9 for 90 minutes, followed by 2 hours of skill training.
Number of subjects: 78

Group type: COMPARATOR
Intervention: Didactic lecture for 90 minutes, followed by 2 hours of skill training.
Number of subjects: 78
Study: 33998949

Group type: EXPERIMENTAL
Intervention: Vaccine with 50% effectiveness
Number of subjects: 1117

Group type: EXPERIMENTAL
Intervention: Vaccine with 95% effectiveness
Number of subjects: 1117
Study: 35985196

Group type: EXPERIMENTAL
Intervention: Oligonol® supplementation (200 mg per day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (dextrin)
Number of subjects: 120
Study: 34410982

Group type: EXPERIMENTAL
Intervention: Medicinal water
Number of subjects: 174

Group type: COMPARATOR
Intervention: Tap water
Number of subjects: 174
Study: 34624157

Group type: EXPERIMENTAL
Intervention: Machined surface (MS) implant sites
Number of subjects: 24

Group type: COMPARATOR
Intervention: Laser-microtextured surface (LMS) implant sites
Number of subjects: 24
Study: 33509031

Group type: EXPERIMENTAL
Intervention: Synchronous water irrigation (experimental group)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No water irrigation (static control group)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No water irrigation (dynamic control group)
Number of subjects: 12
Study: 32168217

Group type: EXPERIMENTAL
Intervention: Low-dose copper (175 mm) intrauterine contraceptive with a flexible nitinol frame
Number of subjects: 286
Study: 35796019

Group type: EXPERIMENTAL
Intervention: NO2 reduction treatment (sham particle filtration and real NO2 scrubbing)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Particle filtration treatment (HEPA filter and sham NO2 scrubbing)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control treatment (sham particle filtration and sham NO2 scrubbing)
Number of subjects: 126
Study: 32500753

Group type: EXPERIMENTAL
Intervention: Polatuzumab vedotin in combination with bendamustine and rituximab (BR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polatuzumab vedotin-BR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polatuzumab vedotin in combination with R-CHOP
Number of subjects: 0
Study: 33331637

Group type: EXPERIMENTAL
Intervention: Dydrogesterone 40 mg orally, followed by 10 mg orally three times a day until 12 completed weeks of gestation or 1 week after bleeding stopped
Number of subjects: 406

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Dydrogesterone
Number of subjects: 406
Study: 35144225

Group type: EXPERIMENTAL
Intervention: Personalized invitations from a physician
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personalized invitations with information about peer screening behavior
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personalized invitations with a labeled but unconditional financial incentive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personal invitations with a conditional financial incentive
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33333328

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus carboplatin or cisplatin plus pemetrexed (APP)
Number of subjects: 578

Group type: COMPARATOR
Intervention: Carboplatin or cisplatin plus pemetrexed (PP)
Number of subjects: 578
Study: 33808079

Group type: EXPERIMENTAL
Intervention: Spirulina supplementation (6 g per day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 36054253

Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg daily plus montelukast 10 mg daily
Number of subjects: 108

Group type: COMPARATOR
Intervention: Doxycycline 100 mg daily plus placebo
Number of subjects: 108
Study: 34126052

Group type: EXPERIMENTAL
Intervention: On-site access to oral PrEP
Number of subjects: 2124

Group type: COMPARATOR
Intervention: No on-site access to oral PrEP (before access)
Number of subjects: 2124

Group type: EXPERIMENTAL
Intervention: On-site access to oral PrEP (within 180 days after access)
Number of subjects: 2124

Group type: COMPARATOR
Intervention: No on-site access to oral PrEP (within 180 days before access)
Number of subjects: 2124
Study: 35405944

Group type: EXPERIMENTAL
Intervention: Probiotic intervention (Bifidobacterium longum R0175, Lactobacillus helveticus R0052, Lactiplantibacillus plantarum R1012)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 22
Study: 32576828

Group type: EXPERIMENTAL
Intervention: Fasting mimicking diet (FMD)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 131
Study: 36498313

Group type: EXPERIMENTAL
Intervention: Adapted swimming activity (exercise intervention)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 33715937

Group type: EXPERIMENTAL
Intervention: Crestal level (CL) implants
Number of subjects: 22

Group type: COMPARATOR
Intervention: Supracrestal level (SL) implants
Number of subjects: 22
Study: 36002047

Group type: EXPERIMENTAL
Intervention: Transcatheter edge-to-edge repair (TEER)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: TEER
Number of subjects: 144
Study: 33023487

Group type: EXPERIMENTAL
Intervention: rTMS treatment for upper limb recovery
Number of subjects: 13
Study: 36128937

Group type: EXPERIMENTAL
Intervention: Hand hygiene intervention (IG)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 191
Study: 32394757

Group type: EXPERIMENTAL
Intervention: Multimodal intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 32567472

Group type: EXPERIMENTAL
Intervention: Insertion of a dual mobility cup (DMC)
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Standard cup (control group)
Number of subjects: 1600
Study: 36223321

Group type: EXPERIMENTAL
Intervention: Laparoscopic proximal gastrectomy (LPG) with gastric tube reconstruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total gastrectomy (TG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 0
Study: 32807159

Group type: EXPERIMENTAL
Intervention: Telemedicine consultation service and standardized operating procedures in network hospitals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardized operating procedures and multiprofessional training scheme
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality management program
Number of subjects: 0
Study: 36385713

Group type: EXPERIMENTAL
Intervention: Topical melatonin (25 mg/g) applied twice daily during radiation therapy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo cream applied twice daily during radiation therapy
Number of subjects: 65
Study: 33402034

Group type: EXPERIMENTAL
Intervention: Sequential-with-tracing presentation of instructional arrows
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequential-without-tracing presentation of instructional arrows
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simultaneous presentation of instructional arrows
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequential presentation of arrows (both types)
Number of subjects: 0
Study: 32890808

Group type: EXPERIMENTAL
Intervention: Transoral rigid laryngeal endoscopy (TORLE)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Transnasal flexible fiberoptic laryngoscopy (TNFFL)
Number of subjects: 96
Study: 34921654

Group type: EXPERIMENTAL
Intervention: Socio-ecological aggression prevention program
Number of subjects: 2042
Study: 35226342

Group type: EXPERIMENTAL
Intervention: Cerebello-motor paired associative stimulation (PAS) coupled with physiotherapy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cerebello-motor PAS
Number of subjects: 27
Study: 33718317

Group type: EXPERIMENTAL
Intervention: Reactive treatment intervention targeting household members of clinical malaria cases
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intervention units defined according to shared sleeping spaces and household membership
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incorporating local definitions and community preference in trial design
Number of subjects: 0
Study: 32075590

Group type: EXPERIMENTAL
Intervention: Prism Adaptation (PA) treatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 42
Study: 35871424

Group type: EXPERIMENTAL
Intervention: Video modeling tooth-brushing education
Number of subjects: 137

Group type: COMPARATOR
Intervention: Social story based tooth-brushing education
Number of subjects: 137
Study: 33951328

Group type: EXPERIMENTAL
Intervention: A VitD group (800 mg calcium and 0.5 μg active vitamin D)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: P-A VitD group (800 mg calcium, 0.5 μg active vitamin D, and physical exercise)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: P-NA VitD group (800 mg calcium, 800 IU non-active vitamin D, and physical exercise)
Number of subjects: 420

Group type: COMPARATOR
Intervention: All groups (including control groups)
Number of subjects: 420
Study: 35665521

Group type: EXPERIMENTAL
Intervention: Baclofen 10 mg t.i.d.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33653635

Group type: EXPERIMENTAL
Intervention: mpMRI for possible MIBC (Likert 3-5)
Number of subjects: 100

Group type: COMPARATOR
Intervention: TURBT
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 5-point Likert scale
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Flexible cystoscopy biopsies
Number of subjects: 100
Study: 32146471

Group type: EXPERIMENTAL
Intervention: Trifluridine-Tipiracil (FTD/TPI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rechallenge with previous treatment lines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personalized approaches based on comprehensive molecular profiling
Number of subjects: 0
Study: 34465252

Group type: EXPERIMENTAL
Intervention: DMF 240 mg twice daily
Number of subjects: 1736

Group type: COMPARATOR
Intervention: PBO/DMF
Number of subjects: 1736

Group type: EXPERIMENTAL
Intervention: DMF/DMF
Number of subjects: 1736

Group type: EXPERIMENTAL
Intervention: DMF
Number of subjects: 1736
Study: 33951595

Group type: EXPERIMENTAL
Intervention: Integrated rice-duck (RD) system
Number of subjects: 180

Group type: COMPARATOR
Intervention: Floor pen rearing (FPR) system
Number of subjects: 180
Study: 35579605

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 226

Group type: COMPARATOR
Intervention: Control
Number of subjects: 226
Study: 32863014

Group type: EXPERIMENTAL
Intervention: Auriculoacupuncture
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control (metoclopramide)
Number of subjects: 68
Study: 35799339

Group type: EXPERIMENTAL
Intervention: SS+CH
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: FS+CH
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: SH+CH
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: SS+MTA
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: FS+MTA
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: SH+MTA
Number of subjects: 55

Group type: COMPARATOR
Intervention: CH
Number of subjects: 55

Group type: COMPARATOR
Intervention: MTA
Number of subjects: 55
Study: 34004092

Group type: EXPERIMENTAL
Intervention: Antipsychotic treatment
Number of subjects: 526
Study: 32980725

Group type: EXPERIMENTAL
Intervention: Radiomic models derived from T1C alone
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Combination of T1C and T2
Number of subjects: 490
Study: 35001564

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (NS)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Diphenhydramine HCl (DH)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 7
Study: 33589391

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study: 35126568

Group type: EXPERIMENTAL
Intervention: 500 mg of Zintoma (ginger rhizome) capsules
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: 250 mg Zintoma capsules
Number of subjects: 128

Group type: COMPARATOR
Intervention: 500 mg placebo capsules (containing chickpea flour)
Number of subjects: 128

Group type: COMPARATOR
Intervention: 250 mg placebo capsules
Number of subjects: 128
Study: 35986257

Group type: EXPERIMENTAL
Intervention: Needle aspiration
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Forceps biopsy
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Combined modalities (needle aspiration and forceps biopsy)
Number of subjects: 142
Study: 34621271

Group type: EXPERIMENTAL
Intervention: B cell depleting therapy (anti-CD20 treatment)
Number of subjects: 30

Group type: COMPARATOR
Intervention: B cell depleting therapy (rituximab vs ofatumumab)
Number of subjects: 30
Study: 33788482

Group type: EXPERIMENTAL
Intervention: Ginger-partitioned moxibustion
Number of subjects: 64

Group type: COMPARATOR
Intervention: Tropisetron hydrochloride intravenous (Control)
Number of subjects: 64
Study: 35483400

Group type: EXPERIMENTAL
Intervention: Imiquimod treatment (self-administered, escalating dosage up to 3 times per week for 4-6 months)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Surgery (excision or ablation)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Imiquimod treatment
Number of subjects: 110

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 110
Study: 34360360

Group type: EXPERIMENTAL
Intervention: Active music intervention
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Receptive music intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 90
Study: 32072388

Group type: EXPERIMENTAL
Intervention: Nomogram for overall survival (OS)
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS)
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Nomogram evaluation using AUC and calibration plots
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Decision curve analysis (DCA)
Number of subjects: 855
Study: 36083023

Group type: EXPERIMENTAL
Intervention: Narration (describing the memory out loud)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imagery (recalling the memory silently)
Number of subjects: 0
Study: 32492148

Group type: COMPARATOR
Intervention: Step 1 diet (30%E fat, 9% SFA)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Low-Sat diet (26%E fat, 5% SFA)
Number of subjects: 188

Group type: COMPARATOR
Intervention: High-MUFA diet (37%E fat, 8% SFA, 22% MUFA)
Number of subjects: 188
Study: 35813289

Group type: EXPERIMENTAL
Intervention: Sevoflurane inhalation with manual infusion of remifentanil
Number of subjects: 82

Group type: COMPARATOR
Intervention: Effect-site target-controlled infusion of propofol and remifentanil
Number of subjects: 82
Study: 33621601

Group type: EXPERIMENTAL
Intervention: Progesterone (100 mg subcutaneously twice daily for up to 5 days)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard of Care (SOC) alone
Number of subjects: 42
Study: 36335033

Group type: EXPERIMENTAL
Intervention: Surgical warm-up using a virtual reality simulator (priming arm)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Usual preparatory routine for surgery (control arm)
Number of subjects: 151
Study: 34321045

Group type: EXPERIMENTAL
Intervention: Children with inherited cardiac disorders
Number of subjects: 214

Group type: COMPARATOR
Intervention: Healthy subjects (age and gender-matched control group)
Number of subjects: 214
Study: 32961293

Group type: EXPERIMENTAL
Intervention: Jaggery-based biofloc system (JB-BFT) at C:N12, C:N15, C:N20
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no carbon source)
Number of subjects: 0
Study: 36148702

Group type: EXPERIMENTAL
Intervention: Exo4Work PSE support
Number of subjects: 0

Group type: COMPARATOR
Intervention: No support (control)
Number of subjects: 0
Study: 32452691

Group type: EXPERIMENTAL
Intervention: Stepping Up, Stepping Out (SUSO) program
Number of subjects: 39
Study: 32145678

Group type: EXPERIMENTAL
Intervention: Clemastine 1 mg orally twice a day for 90 days
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo for 90 days
Number of subjects: 25
Study: 33541650

Group type: EXPERIMENTAL
Intervention: Gluten-starch interaction
Number of subjects: 16

Group type: COMPARATOR
Intervention: Gluten
Number of subjects: 16
Study: 34062283

Group type: EXPERIMENTAL
Intervention: Eccentric cycling (ECC)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Concentric cycling (CON)
Number of subjects: 14
Study: 36050407

Group type: EXPERIMENTAL
Intervention: Classification decision tree model for GFR estimation
Number of subjects: 518
Study: 34206346

Group type: EXPERIMENTAL
Intervention: Resisted Sprint Training (RST)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Plyometric Training (PT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 90
Study: 32962422

Group type: COMPARATOR
Intervention: a‐tPCS at 4 Hz
Number of subjects: 15

Group type: COMPARATOR
Intervention: c‐tPCS at 4 Hz
Number of subjects: 15

Group type: COMPARATOR
Intervention: a‐tPCS at 75 Hz
Number of subjects: 15

Group type: COMPARATOR
Intervention: c‐tPCS at 75 Hz
Number of subjects: 15
Study: 35921997

Group type: EXPERIMENTAL
Intervention: New multilayer hypoallergenic coating system
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard implant
Number of subjects: 120
Study: 33518311

Group type: EXPERIMENTAL
Intervention: Dietary resistant potato starch (RPS) 12%
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (0% RPS)
Number of subjects: 96
Study: 32527365

Group type: EXPERIMENTAL
Intervention: Notification slips (NS standard of care)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: NS and text messages (SMS)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: NS and telephone calls
Number of subjects: 442

Group type: COMPARATOR
Intervention: Control group (NS only)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Overall attendance
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Partner non-treatment
Number of subjects: 442